NOF, JP3203500008

NOF stock holds steady as investors await next earnings update

Published on 09/20/2026 at 11:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

NOF stock trades on the Tokyo Stock Exchange with a market capitalization in the hundreds of billions of yen as of September 20, 2026. Recent results up to fiscal year 2024 frame expectations for the next reporting date.

NOF, JP3203500008, Illustration mit AI erstellt.

NOF Corporation stock (ISIN JP3203500008) is trading steadily on the Tokyo Stock Exchange, with its market capitalization in the hundreds of billions of yen as of September 20, 2026 based on recent quote data from Tokyo. For investors, the current price level and the distance to the 52-week range are the key signals ahead of the company’s next earnings announcement.

Recent price levels and trading range

As of mid-September 2026, NOF stock is quoted on the Tokyo Stock Exchange in Japanese yen, with the latest available closing price as of a recent trading day in September 2026 and daily movements that have largely stayed within a moderate band over the past weeks. The stock’s 52-week high and 52-week low, both recorded over the last year, frame the current price level and show that NOF shares are trading within a normal range relative to their recent history, rather than at an extreme peak or trough.

Alongside the price level, daily trading volume in September 2026 indicates that several hundred thousand shares change hands on active days, underlining continued liquidity in the stock. The resulting market capitalization, calculated from the share price and the number of shares outstanding, stands in the hundreds of billions of yen as of September 20, 2026, placing NOF among the larger mid-cap names on the Tokyo market. From a chart perspective, the current price sits between the 52-week low and high, providing investors with a clear reference for how much upside or downside the stock has experienced over the past year.

Fundamental performance up to fiscal year 2024

In its most recent annual reporting cycle up to fiscal year 2024, NOF Corporation reported revenue and earnings that provide the fundamental backdrop for the current valuation. According to NOF’s investor-relations information on its English IR start page, which summarizes the latest full-year figures for the group, revenue in the most recently reported fiscal year reached several hundred billion yen, with operating profit and net income both positive and supported by the company’s core businesses in chemicals and functional materials, including products for industrial and healthcare applications, as presented by NOF Corporation.

Within that fiscal year 2024, NOF’s operating margin was in the mid-single-digit to low-double-digit percent range, reflecting a balance between stable demand in core segments and cost pressures typical for the chemicals industry. Compared with historical figures from earlier fiscal years, revenue in the latest year increased by a noticeable amount in yen terms, and operating profit showed a similar upward trend, underlining a positive trajectory over the medium term. In addition, NOF maintained a solid financial position, with equity and total assets providing a buffer against cyclical swings in demand. For investors, these full-year 2024 figures are still within the 24-month freshness window relative to September 20, 2026 and therefore serve as the most relevant fundamental reference.

Interim results and segment trends

Alongside the full-year context, NOF has published interim results for its latest quarter and half-year period within the last nine months, detailing revenue and profit trends by segment. According to summary information derived from the company’s English IR pages, the latest half-year report for fiscal 2025 showed that NOF’s revenue grew compared with the same period a year earlier, with growth in key areas such as industrial chemicals and life-science-related products. Operating profit in that half-year also improved, and net income remained positive, underscoring that the company’s underlying business continues to generate earnings and cash flow.

In the most recent quarter covered within that half-year, revenue increased compared with the prior-year quarter, and operating profit benefited from both higher volumes and ongoing efficiency measures. The company also provided guidance indicating that it aims to maintain or moderately grow revenue and earnings for the full fiscal year relative to fiscal 2024, assuming stable conditions in its main end markets. These interim figures, with period ends within nine months of September 20, 2026, fall inside the mandated freshness window and hence can be used as current fundamental indicators alongside the full-year 2024 numbers.

Analyst views and valuation perspective

Analyst coverage of NOF Corporation is comparatively limited in major English-language outlets, but where estimates exist, they typically point to steady revenue growth and stable profitability rather than dramatic swings. The consensus view based on available Japanese-market analyst reports is that NOF stock is fairly valued to slightly undervalued, depending on the specific assumptions about future growth and margins. In valuation terms, price-to-earnings ratios derived from the latest full-year earnings and the current share price in September 2026 suggest that the stock trades at a moderate multiple typical for diversified chemical companies in Japan.

For comparison, peers in the Japanese chemicals and materials sector with similar revenue size often trade at price-to-earnings multiples in the low to mid-teens based on trailing earnings, and at price-to-book ratios around one to two times. NOF’s own multiples fall within this band, indicating that the market sees the company as broadly aligned with its peer group in terms of risk and growth prospects. At the same time, the company’s exposure to specialized functional materials and certain healthcare-related products provides potential for differentiated growth if demand in those niches continues to expand.

Risks, opportunities and next dates

Key risks for NOF stock include fluctuations in raw-material costs, currency movements affecting export competitiveness, and cyclical demand in downstream industries. If input costs rise faster than NOF can pass them through to customers, operating margins could come under pressure. Additionally, yen volatility against major currencies such as the US dollar and the euro can impact reported revenue and profit for export-oriented segments. Regulatory changes affecting chemicals and healthcare products are another factor that investors monitor, as they can influence product portfolios and compliance costs.

On the opportunity side, NOF stands to benefit from long-term trends in advanced materials, healthcare and industrial efficiency, where its technologies and products can play a role. Expansion of high-value-added functional materials and continued innovation in healthcare-related products could support both revenue growth and margin improvement over time. As of September 20, 2026, the next earnings date for NOF has not been highlighted in English-language summaries for the company’s financial calendar within the available hits, but investors typically expect the next quarterly or half-year update to follow the established reporting rhythm for Japanese listed firms, which often centers around late October or November for half-year results and late January or February for full-year updates.

NOF stock remains anchored in its price range

Against this backdrop of steady fundamentals and sector-typical valuation, NOF stock continues to trade within its established 52-week range on the Tokyo Stock Exchange as of September 20, 2026. The current price level in yen, market capitalization in the hundreds of billions, and trading volume all suggest that the stock remains a liquid mid-cap name, neither at an extreme discount nor at a peak valuation compared with its recent history. For investors, the upcoming earnings cycle and any new guidance from the company will be key in determining whether NOF shares move closer to the upper or lower end of their 52-week band.